Literature DB >> 26275416

Self-perceived risk and prevalent chlamydia infection among adolescents in Norway: a population-based cross-sectional study.

Kirsten Gravningen1, Tonje Braaten2, Henrik Schirmer3.   

Abstract

OBJECTIVES: Risk judgements are key factors in adolescents' decisions related to sexual health. We examine the associations between self-perceived risk and prevalent chlamydia infection, and sexual behaviours related to risk perception in a general adolescent population in Norway.
METHODS: Population-based cross-sectional study among 1028 sexually experienced girls and boys, age 15-20 years (85% participation), including web questionnaires and urine samples for Chlamydia trachomatis PCR testing. Participants rated self-perceived risk as: no/low/medium/high/very high. We used binary and ordinal logistic regressions to examine associations with chlamydia prevalence and self-perceived risk, respectively, adjusting for potentially confounding variables.
RESULTS: Chlamydia prevalence increased with increasing risk perception. Although girls had twice the chlamydia prevalence of boys (7.3% vs 3.9%), their risk distribution was similar and 65% of both genders rated their risk as no/low with half of infections detected in this group. In multivariable analyses, reporting multiple sexual risk behaviours, non-steady relationship, previous chlamydia testing and treatment, and urogenital symptoms increased self-perceived risk. More boys overestimated their personal risk whereas more girls underestimated it (52% vs 30%, respectively, and 15% vs 31%, p<0.001). The main reasons for perceiving no/low risk were: 'I have a steady partner' and 'I trust my partner will tell me about an infection'.
CONCLUSIONS: These sexually experienced adolescents acknowledged their chlamydia infection risk, but wrong beliefs were incorporated in their assessments, and more than half had incorrect risk perception. We suggest that sexually transmitted infection prevention programmes should be directed at closing the gap between perceived and actual risk and focus on how context may bias personal judgement. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  ADOLESCENT; CHLAMYDIA INFECTION; SEXUAL BEHAVIOUR

Mesh:

Year:  2015        PMID: 26275416     DOI: 10.1136/sextrans-2014-051927

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Double trouble: modelling the impact of low risk perception and high-risk sexual behaviour on chlamydia transmission.

Authors:  Daphne A van Wees; Chantal den Daas; Mirjam E E Kretzschmar; Janneke C M Heijne
Journal:  J R Soc Interface       Date:  2018-04       Impact factor: 4.118

2.  Significant Associations between Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Human Immunodeficiency Virus-Infected Pregnant Women.

Authors:  Bongekile Ngobese; Khine Swe Swe-Han; Partson Tinarwo; Nathlee S Abbai
Journal:  Infect Dis Obstet Gynecol       Date:  2022-06-17

3.  Trends in risk behaviors and sexually transmitted infections among youth presenting to a sexually transmitted infection clinic in the United States, 2013-2017.

Authors:  Jack C Rusley; Jun Tao; Daphne Koinis-Mitchell; Alex E Rosenthal; Madeline C Montgomery; Hector Nunez; Philip A Chan
Journal:  Int J STD AIDS       Date:  2022-04-06       Impact factor: 1.456

4.  STI Risk Perception in the British Population and How It Relates to Sexual Behaviour and STI Healthcare Use: Findings From a Cross-sectional Survey (Natsal-3).

Authors:  Soazig Clifton; Catherine H Mercer; Pam Sonnenberg; Clare Tanton; Nigel Field; Kirsten Gravningen; Gwenda Hughes; Fiona Mapp; Anne M Johnson
Journal:  EClinicalMedicine       Date:  2018 Aug-Sep

5.  Behavioral intention to have risky sex in young men and women: The role of sexual excitation and assertiveness.

Authors:  Reina Granados; Nieves Moyano; Juan Carlos Sierra
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.